Director of Resmed board resigns

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

A director of the Resmed (ASX: RMD) board has resigned, reducing the number of board members to eight.

Donagh McCarthy, president of the renal division of Baxter Healthcare in the US, has declined to stand for re-election to the board.

The remaining board members decided that instead of finding a replacement for McCarthy, the board would be reduced to eight.

Resmed founder Dr Peter Farrell will continue to hold the post of executive director of the board.

Farrell had previously arranged to become non-executive chairman by June 30.

Related News

Organoid platform enables closer study of bat-borne viruses

Reconstructing bat organ physiology in the lab lets scientists explore how zoonotic viruses work...

Global study finds 250 genes linked to OCD

Researchers say they have found the genes linked to obsessive compulsive disorder (OCD), after...

TGA approves therapy for paediatric growth hormone deficiency

The TGA has approved SKYTROFA as a treatment for growth failure in children and adolescents aged...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd